PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 24, 2026Health Science Reports2 citationsOpen Access

Molecular Pathogenesis of Memory Impairment in Parkinson's Disease: An Exploration of Underlying Mechanisms

View Full Paper
MPMohammad PourfridoniZHZohreh HakemiHMHabibeh Mashayekhi‐sardoo

Key Points

  • The aim is to clarify the molecular mechanisms contributing to memory impairment in Parkinson's disease.
  • Conducted a narrative review of literature on cognitive deficits in Parkinson's disease.
  • Examined animal studies and clinical research on molecular changes related to memory impairment.
  • Synthesized findings related to dopaminergic depletion and other contributory factors.
  • Identified key molecular mechanisms impacting memory, such as dopamine depletion and neuroinflammation.
  • Noted additional factors like cholinergic dysfunction and altered neurotransmitter systems affecting cognitive function.
  • Illustrated how various mechanisms collectively contribute to memory deficits in Parkinson's disease.

Abstract

ABSTRACT Background and Aim Parkinson's disease (PD) is primarily known for its motor symptoms but is increasingly recognized for its substantial cognitive effects, particularly on memory. This narrative review aims to clarify the complex molecular mechanisms contributing to memory impairment in PD by integrating findings from both animal and clinical research. Methods This study is a narrative review synthesizing data from existing literature. It begins by addressing the prevalence of cognitive deficits among PD patients. It then explores animal studies investigating pathophysiological changes associated with PD, focusing on the impact of dopaminergic depletion on neural circuitry. These findings are integrated with clinical research to identify specific molecular changes closely associated with memory impairment independent of motor dysfunction. Results The review systematically examines key molecular mechanisms contributing to memory deficits in PD. These mechanisms include disruptions in neural circuits, dopamine depletion, neuroinflammation, oxidative stress, and alpha‐synuclein pathology. Additional contributing factors identified include cholinergic system dysfunction, cortical thinning and atrophy, disrupted neural oscillations, gut‐brain axis dysfunction, impaired synaptic plasticity, and alterations in neurotransmitter systems. The analysis illustrates how these factors collectively undermine cognitive function. Conclusion By synthesizing insights from various studies, this narrative review offers a comprehensive perspective on the intricate molecular pathogenesis of memory impairment in PD. It underscores the necessity of addressing both motor and non‐motor symptoms in managing PD effectively and advocates for a holistic treatment approach that considers cognitive decline alongside traditional motor symptom management.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pourfridoni et al. (2026) studied this question.

synapsesocial.com/papers/69eb09c9553a5433e34b4295https://doi.org/10.1002/hsr2.72024
Ask AI
Helpful
Bookmark
Share
View Full Paper